Details for New Drug Application (NDA): 076928
✉ Email this page to a colleague
The generic ingredient in LAMOTRIGINE is lamotrigine. There are thirty-two drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the lamotrigine profile page.
Summary for 076928
Tradename: | LAMOTRIGINE |
Applicant: | Watson Labs |
Ingredient: | lamotrigine |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 2MG | ||||
Approval Date: | Jan 22, 2009 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 5MG | ||||
Approval Date: | Jan 22, 2009 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 25MG | ||||
Approval Date: | Jan 22, 2009 | TE: | AB | RLD: | No |
Complete Access Available with Subscription